R2 Technology registers for IPO
Privately held R2 Technology has taken the first step toward going public. The pioneer of computer-assisted diagnosis has filed a registration statement with the Securities and
Privately held R2 Technology has taken the first step toward going public. The pioneer of computer-assisted diagnosis has filed a registration statement with the Securities and Exchange Commission for an initial public offering of common stock. Net proceeds will be used for general corporate purposes, including working capital, R&D, sales and marketing, clinical and regulatory studies, and capital expenditures. A portion may also be used to acquire or invest in complementary businesses, products, and technologies. R2 develops, manufactures, and sells proprietary medical systems to assist radiologists in the detection of cancer. The company's ImageChecker CAD system analyzes medical images, marking features that may indicate cancer. Prior to the registration, the company secured $14 million in venture capital financing. That round brought the total of VC financing to $76 million since the company was incorporated in 1993.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
